You Can Shop At Amazon and Help Support Emergency-Preps.com Without It Costing You One Thin Dime - Click Here to Learn How!
0 Members and 1 Guest are viewing this topic.
Renowned Boston oncologist Dr. Sidney Farber pioneered a treatment in the late 1940s to beat a childhood cancer long thought to be incurable. Today, however, children diagnosed with the disease, acute lymphoblastic leukemia, face another threat: a shortage of one of the drugs Farber used to cure it.A plant that made much of the country’s supply of preservative-free methotrexate -- what Al Patterson, pharmacy director at Children’s Hospital Boston, called the “cornerstone” in Farber’s treatment plan -- closed last year. The supply at Patterson’s hospital may last just 10 days, he said today, and hospitals across the country are facing similar shortages.“There is no light at the end of the tunnel, yet, that we see,” he said.Patterson was among about a dozen health care leaders who testified before the state Legislature’s Joint Committee on Public Health today about the effects of the growing problem of drug shortages linked to manufacturing problems and the rise of what the speakers described as the “grey market,” in which drug suppliers stockpile medications, then sell them at inflated prices.The shortages are particularly severe among drugs that are injected intravenously because they require more complex manufacturing facilities to maintain sterility. They have affected many aspects of medical care, including cancer treatment, anaesthesia, psychiatric care, and the administration of intravenous nutrition.In a survey last year by the American Hospital Association of 820 acute care hospitals, nearly all reported experiencing drug shortages. Eight-two percent said they had delayed patient care as a result, and 69 percent said patients had received a less effective drug.“The situation has devolved into a public health crisis that threatens our ability not only to provide routine and timely medical care to patients in need, but also to save the lives of people suffering from what should be preventable, treatable and curable health conditions,” said Representative Jeffrey Sánchez, a Democrat from Jamaica Plain and chairman of the committee.The list of medically necessary drugs in short supply has grown from 61 in 2005 to about 250 last year, said Dr. Sandra Kweder of the US Food and Drug Administration Center for Drug Evaluation and Research....
I'm not sure if it's the DEA or the FDA (or both), but some other 3 letter agency apparently has a role as well...all in the name of the War on Drugs.Apparently the Feds calculate anticipated demand, then allocate rations of precursor chemicals accordingly.Of course, if when demand is higher than the Feds forecast, you get problems.
Started by TsMom
General Medical Discussions